update on phase ii study of ibrutinib in patients with classic and variant hairy cell leukemia
Published 1 year ago • 228 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
1:46
preclinical efficacy of the pkcβ inhibitor ms-553 in btki resistant cll
-
1:29
phase ii evaluates vemurafenib/obinutuzumab in hairy cell leukemia
-
0:32
patient selection for ctcl
-
1:09
hairy cell leukemia - without a ribbon
-
2:17
dr. tiacci on vemurafenib/rituximab combo in hcl
-
1:12
precursor conditions for cll | #cll
-
12:03
pegcetacoplan in patients with c3g and primary ic-mpgn
-
1:24
kd033, a pdl1-1l15 bispecific molecule for the treatment of cancer
-
1:01
study reveals promising therapy for hairy cell leukemia
-
0:46
hairy cell leukemia [usmle brief review] #shorts
-
2:44
current & emerging therapies for classic and variant hcl
-
0:30
abcdefgh of hairy cell leukemia..
-
4:13
ibrutinib as a treatment option for hairy cell leukemia
-
5:19
hcl management: recommendations and advice
-
1:15
hello tellomak: new trial for t-cell lymphoma
-
3:48
ctcl overview (chapter 1)
-
1:40
dr. ravi vij discussing with leslie andritsos md on hairy cell leukemia (hcl) at @mycancerhaven
-
3:46
6 3 hairy cell leukaemia hcl
-
0:26
hairy cell leukemia